| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corcept Therapeutics Incorporated (CORT) has 10 insiders with recent SEC Form 4 filings, including 10 buys and 7 sells. CORT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.57M | $204.82M | -12,837 | |
| Dir | 1.15M | $91.54M | - | |
| Other | 190.0K | $15.17M | - | |
| Other | 84.0K | $6.70M | -75,000 | |
| Other | 78.6K | $6.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2019 | Baker G Leonard Jr | Director | Sale+OE | 30,000 | $9.78 | $293,298.00 | -2.9% | |
| Feb 12, 2019 | Baker G Leonard Jr | Director | Buy | 100,000 | $11.39 | $1,138,710.00 | +2.5% | |
| Dec 12, 2018 | Robb Gary Charles53 | Chief Financial Officer | Sale+OE | 25,000 | $19.01 | $475,152.50 | -78.5% | |
| Dec 12, 2018 | Belanoff Joseph K77 | Chief Executive Officer | Sale+OE | 217,115 | $19.01 | $4,126,509.40 | -9.1% | |
| Dec 12, 2018 | Maduck Sean53 | See Remarks | Sale+OE | 60,000 | $19.01 | $1,140,366.00 | -75.0% | |
| Nov 21, 2018 | Baker G Leonard Jr | Director | Buy | 100,000 | $12.73 | $1,272,550.00 | +2.6% | |
| Nov 13, 2018 | Baker G Leonard Jr | Director | Buy | 200,000 | $12.95 | $2,589,229.97 | +1.8% | |
| Nov 7, 2018 | Fishman Robert S | Chief Medical Officer | Sale+OE | 8,000 | $13.74 | $109,887.20 | -100% | |
| Oct 8, 2018 | Fishman Robert S | Chief Medical Officer | Sale+OE | 8,000 | $13.19 | $105,537.60 | -100% | |
| Sep 7, 2018 | Fishman Robert S | Chief Medical Officer | Sale+OE | 8,000 | $14.57 | $116,532.80 | -100% |